Detalhe da pesquisa
1.
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 51(2): 558-567, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37736808
2.
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
Eur J Nucl Med Mol Imaging
; 50(8): 2529-2536, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905411
3.
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.
Eur J Nucl Med Mol Imaging
; 50(8): 2537-2547, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929180
4.
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis.
Eur J Nucl Med Mol Imaging
; 50(1): 218-227, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984452
5.
Low-dose radiotherapy for painful osteoarthritis of the elderly: A multicenter analysis of 970 patients with 1185 treated sites.
Strahlenther Onkol
; 197(10): 895-902, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34342662
6.
Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis.
Strahlenther Onkol
; 197(9): 812-819, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33938966
7.
Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer.
Eur J Nucl Med Mol Imaging
; 48(6): 1987-1997, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33210239
8.
Evidence for a dysfunction and disease-promoting role of the circadian clock in the diabetic retina.
Exp Eye Res
; 211: 108751, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478739
9.
Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients.
Eur J Nucl Med Mol Imaging
; 47(12): 2796-2803, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342192
10.
[Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer]. / Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms.
Strahlenther Onkol
; 200(3): 250-252, 2024 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-38289359
11.
[Influence of adjuvant vs early salvage radiotherapy on lethality in men with high risk for recurrence following radical prostatectomy for prostate cancer]. / Einfluss einer adjuvanten Strahlentherapie im Vergleich zur "Early-salvage-Strahlentherapie" auf die Letalität von Männern mit einem hohen Rezidivrisiko nach radikaler Prostatektomie wegen Prostatakarzinom.
Strahlenther Onkol
; 198(1): 89-92, 2022 01.
Artigo
em Alemão
| MEDLINE | ID: mdl-34825252
12.
[Failure patterns following external beam radiotherapy with or without additional focal boost in the randomized FLAME trial for localized prostate cancer]. / Das Rezidivmuster nach perkutaner Strahlentherapie mit und ohne zusätzliche fokale Dosiseskalation innerhalb der randomisierten FLAME-Studie für das lokale Prostatakarzinom.
Strahlenther Onkol
; 198(9): 869-872, 2022 09.
Artigo
em Alemão
| MEDLINE | ID: mdl-35579679
13.
[10-Year mortality, disease progression, and treatment-related side effects in men with localized prostate cancer from the ProtecT Randomised Controlled Trial, analyzed according to treatment received]. / 10-Jahres-Letalität, Krankheitsprogress und behandlungsassoziierte Nebenwirkungen bei Männern mit lokalisiertem Prostatakarzinom aus der randomisierten, kontrollierten ProtecT-Studie, analysiert nach erhaltener Therapie.
Strahlenther Onkol
; 197(7): 651-654, 2021 07.
Artigo
em Alemão
| MEDLINE | ID: mdl-33963439
14.
Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis.
Front Oncol
; 14: 1371384, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38737910
15.
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside.
Theranostics
; 14(6): 2560-2572, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646643
16.
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy.
Radiother Oncol
; 194: 110215, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458259
17.
A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation.
Int J Radiat Oncol Biol Phys
; 118(5): 1282-1293, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914144
18.
Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer.
Front Oncol
; 13: 1210879, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37409247
19.
A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment.
Res Sq
; 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014120
20.
Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer.
Radiother Oncol
; 188: 109774, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37394103